Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Cancer Research
|
July 31, 2025
Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma
Rui-Zhe Li, Guo-Qiang Pan, Chen Xiong, et al.
Frontiers in Immunology
|
April 25, 2022
The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Jun-Shuai Xue, Zi-Niu Ding, Guang-Xiao Meng, et al.
Clinical and Experimental Medicine
|
November 17, 2022
Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis
Jin-Cheng Tian, Hui Liu, Lun-Jie Yan, et al.
Expert Review of Gastroenterology & Hepatology
|
January 10, 2023
The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis
Cheng-Long Han, Bao-Wen Tian, Chun-Cheng Yang, et al.
International Immunopharmacology
|
December 2, 2022
Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis
Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, et al.
Journal of Cancer
|
June 7, 2021
RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival
Zhao-Ru Dong, Zhi-Qiang Chen, Xiao-Yun Yang, et al.
Expert Review of Anticancer Therapy
|
April 16, 2024
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis
Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, et al.
Cancer Cell International
|
August 31, 2023
MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway
Guang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, et al.
Biomarker Research
|
October 4, 2023
A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients
Xin-Cheng Mao, Shuo Shi, Lun-Jie Yan, et al.
Immunotherapy
|
December 20, 2022
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis
Bao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Cancer Research
|
July 31, 2025
Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma
Rui-Zhe Li, Guo-Qiang Pan, Chen Xiong, et al.
Frontiers in Immunology
|
April 25, 2022
The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Jun-Shuai Xue, Zi-Niu Ding, Guang-Xiao Meng, et al.
Clinical and Experimental Medicine
|
November 17, 2022
Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis
Jin-Cheng Tian, Hui Liu, Lun-Jie Yan, et al.
Expert Review of Gastroenterology & Hepatology
|
January 10, 2023
The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis
Cheng-Long Han, Bao-Wen Tian, Chun-Cheng Yang, et al.
International Immunopharmacology
|
December 2, 2022
Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis
Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, et al.
Journal of Cancer
|
June 7, 2021
RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival
Zhao-Ru Dong, Zhi-Qiang Chen, Xiao-Yun Yang, et al.
Expert Review of Anticancer Therapy
|
April 16, 2024
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis
Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, et al.
Cancer Cell International
|
August 31, 2023
MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway
Guang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, et al.
Biomarker Research
|
October 4, 2023
A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients
Xin-Cheng Mao, Shuo Shi, Lun-Jie Yan, et al.
Immunotherapy
|
December 20, 2022
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis
Bao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, et al.
Page
of 8